Hypercholesterolemia Market Revenue Poised for Significant Growth During the Forecast Period
The global hypercholesterolemia market size was USD 12.95 Billion in 2021 and is expected to register a revenue CAGR of 15.7% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cardiovascular diseases and chronic disorders and rising number of clinical studies and trials for treatment of hypercholesterolemia are crucial factors driving market revenue growth. In addition, rapid advancement of clinical drug development for hypercholesterolemia in the recent years is another factor expected to drive revenue growth of the market.
Hypercholesterolemia is defined as high amounts of Low-Density lipoprotein Cholesterol (LDL-C) or non-High-Density Lipoprotein cholesterol (HDL-C), dyslipidemia comprises excessive triglycerides, low levels of HDL-C, and qualitative lipid abnormalities.
Have a look on Free Demo Version @ https://www.emergenresearch.co....m/request-sample/139